Aragen Life Sciences
Aragen Life Sciences is a prominent discovery research and development organization in Asia, providing a comprehensive range of services across the R&D and manufacturing value chain. The company specializes in drug discovery, clinical development, contract manufacturing, formulation, and informatics, catering to the needs of healthcare institutions and other sectors. With over a decade of experience in delivering innovative drug discovery and development services, Aragen is equipped with a team of skilled scientists and advanced technologies that enable them to achieve exceptional results for their clients. The organization employs approximately 2,400 professionals and serves a diverse global customer base, including prominent players in pharmaceuticals, agrochemicals, electronics, biotechnology, and academia. Aragen Life Sciences is recognized for its commitment to quality, speed, and affordability, consistently meeting and exceeding customer expectations in their research endeavors.
Intox is a pre-clinical contract research organization that provides a comprehensive array of non-clinical in-vivo and in-vitro research services. The company primarily serves clients in the pharmaceutical, biopharmaceutical, plant protection, nutraceutical, and medical device sectors. Intox specializes in conducting various safety assessment studies, including mammalian, acute, sub-chronic, chronic, and reproductive toxicity studies, as well as in-vitro toxicity, mutagenicity, and environmental toxicity assessments. By offering these research and testing services, Intox enables its clients to fulfill their product development and registration requirements effectively.
Vanta Bioscience
Acquisition in 2014
Vanta Bioscience Limited operates as a preclinical contract research organization based in Secunderabad, India, with additional research laboratories in Chennai and offices in Brussels and West Des Moines. The company provides a wide range of preclinical safety assessment services to clients across various industries, including pharmaceuticals, medical devices, biotechnology, cosmetics, agrochemicals, and nutraceuticals. Its offerings encompass toxicology testing, biocompatibility studies, chemical safety assessments, and risk evaluations for active pharmaceutical ingredients and other materials. Vanta Bioscience also engages in research and development activities, focusing on drug discovery, biological products, vaccines, gene-based therapies, diagnostics, and cosmetic research. Established in 2016, the organization is dedicated to delivering comprehensive non-clinical safety assessment services on a global scale.
Aragen Bioscience
Acquisition in 2014
Aragen Bioscience, Inc. offers preclinical contract research and development services, focusing on various solutions for the pharmaceutical and biotechnology sectors. The company specializes in recombinant cell line and hybridoma development, alongside cell culture and protein purification process development. Its services include primary and immortalized cell-based assays, in vivo models of human disease, and custom immunological services. Aragen's expertise encompasses molecular biology, cell culture, bio-production, and protein chemistry, which support the development of monoclonal antibodies for research, diagnostics, and therapeutic applications. The company also provides in vivo services, including pharmacokinetic studies, pharmacology, and disease modeling. Founded in 2006 and headquartered in Morgan Hill, California, Aragen Bioscience operates as a subsidiary of GVK Biosciences Private Limited.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.